Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS)

CNY 12.25

(4.08%)

Annual Cash Flows

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Operating Cash Flow -478.24 Million -326.79 Million -433.93 Million 155.17 Million 220.92 Million 367.4 Million
Net Income 467.58 Million 190.88 Million 332.75 Million 437.5 Million 405.84 Million 463.4 Million
Depreciation & Amortization 190.43 Million 169 Million 137.1 Million 155.88 Million 138.41 Million 122.4 Million
Deferred income taxes -43.43 Million -78.46 Million -7.95 Million -34.77 Million 12.81 Million -43.23 Million
Stock-based compensation 2.22 Million - - - - -
Change in working capital -929.67 Million -764.02 Million -934.61 Million -629.69 Million -538.56 Million -423 Million
Other non-cash items 145.91 Million 77.35 Million 30.81 Million 191.48 Million 215.22 Million 204.59 Million
Investing Cash Flow 176.42 Million 283.93 Million -421.25 Million -1.45 Billion -260.76 Million -433.76 Million
Investments in PPE -95.13 Million -404.27 Million -448.63 Million -868.64 Million -178.78 Million -419.59 Million
Acquisitions 94.86 Million 352.22 Million 373 Million 50 Million 124.93 Thousand -17.4 Million
Investment purchases -67 Million -4 Million -785.17 Million -893.3 Million -82.1 Million -900 Thousand
Sales/Maturities of investments 20.34 Million 293.34 Million 41.95 Million 260.19 Million -124.93 Thousand 4 Million
Other Investing Activities 93.9 Million 46.63 Million 397.59 Million 872.06 Thousand 124.93 Thousand 132.15 Thousand
Financing Cash Flow 765.69 Million -418.94 Million 797.45 Million 292.1 Million 328.82 Million 517.93 Million
Debt repayment -223 Million -1.71 Billion -278.11 Million -1.61 Billion -1.99 Billion -1.42 Billion
Dividends payments -26.26 Million -99.84 Million -143.72 Million -184.26 Million -139.26 Million -232.69 Million
Common Stock Repurchased - -29.99 Million - - 3.13 Million -
Common Stock Issuance - 29.99 Million -8.78 Million - -3.13 Million -
Other Financing Activities 700.97 Million 1.53 Billion 1.21 Billion 2.24 Billion 2.57 Billion 2.17 Billion
Accounts receivables -891.41 Million 107.18 Million 2.27 Billion -548.79 Million -746.15 Million -211.9 Million
Accounts payables -277.48 Million -521.85 Million -3.58 Billion 170.89 Million -337.3 Million -49.99 Million
Inventory 282.66 Million -270.89 Million 381.01 Million -217.01 Million 532.08 Million -117.87 Million
Other working capital -320.92 Million -78.46 Million -7.95 Million -34.77 Million 12.81 Million -305.13 Million
Cash at beginning of period 982.31 Million 1.44 Billion 1.5 Billion 2.5 Billion 2.21 Billion 1.76 Billion
Cash at end of period 1.44 Billion 982.31 Million 1.44 Billion 1.5 Billion 2.5 Billion 2.21 Billion
Capital Expenditure -95.13 Million -404.27 Million -448.63 Million -868.64 Million -178.78 Million -419.59 Million
Effect of forex changes on cash - 0.48 0.91 0.19 1.10 0.92
Net cash flow / Change in cash 463.87 Million -461.8 Million -57.73 Million -1 Billion 288.98 Million 451.57 Million
Free Cash Flow -573.38 Million -731.06 Million -882.56 Million -713.47 Million 42.13 Million -52.18 Million

Cash Flow Charts